Search results
Independent Advisor Alliance Has $740,000 Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 7 days agoIndependent Advisor Alliance decreased its position in GSK plc (NYSE:GSK – Free Report) by 8.9% in the 4th quarter, according to the company in its most ...
GSK Plc ADR (GSK): Worth A Small Bite At $45.15 – Stocks Register
Stocks Register· 4 days agoGSK Plc ADR (NYSE:GSK) concluded the trading at $45.15 on Thursday, May 23 with a fall of -1.38% from its closing price on previous day. Taking a look at ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 6 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via AOL· 6 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
GSK Faces Whistleblower Suit From Lab That Found Zantac Risk
Insurance Journal· 7 days agoGSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 4 days agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note issued to investors ...
First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers
Bloomberg· 4 days agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 4 days agoGSK’s Study Data: GSK plc GSK announced its two late-stage studies on pipeline candidate depemokimab...
GSK's New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg· 7 days agoWhen Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via Yahoo Finance· 5 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...